HomeOpen Access NewsInfectious Diseases

Infectious Diseases

Oxford’s Nipah virus vaccine wins EMA PRIME status in UK first

The University of Oxford has become the first UK academic institution to receive support from the European Medicines Agency's (EMA) PRIority MEdicines (PRIME) scheme for its vaccine targeting the deadly Nipah virus.

New study investigates link between COVID-19 and risk of blood clots

People who have recovered from COVID-19 may be at risk of developing blood clots due to an overactive immune response, according to a new study.

Asthma drug shortens COVID-19 recovery time

Budesonide, a drug used to treat asthma, has been found to shorten recovery time in COVID-19 patients who are treated at home.

Center for Disease Control says surfaces “low-risk” for COVID transmission

New CDC guidelines suggest that surfaces are a "low-risk" for COVID transmission - cleaning surfaces with detergent or soap once a day should be enough to reduce possible virus levels.

1 in 10 suffer long-term effects 8 months after mild COVID-19 infection

According to a new study, by researchers at Danderyd Hospital and Karolinska Institutet in Sweden, 1 in 10 people still experience symptoms of COVID-19 8 months after infection.

How can touch-free technology help the NHS?

Here, Videx UK highlights how innovative hands-free door entry can help services return to normalcy post-COVID-19.

UV-C disinfection could be the solution to a COVID-safe return to school

Jarek Salek, Head of Engineering and Technical Operations at Uvisan, explains how UV-C cleaning in educational facilities can make shared equipment safe from COVID and help resume teaching that involves computers and other shared hardware.

Africa: Strengthening public health surveillance systems

Several seasoned academic experts describe the move towards strengthening public health surveillance systems in Africa.

Llamas create COVID-19 antibodies that humans can inhale as a vaccine

Scientists at the University of Pittsburgh are creating COVID-19 antibodies in llamas, to understand how humans could engineer better immune responses.

Plague: The first pandemic disease

Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, writes in detail about plague, the first pandemic disease including comment on bacteria.

Care home residents will be allowed one visitor from today

As part of the government's roadmap to ease lockdown restrictions, care home residents will be allowed one indoor visitor from the 8th of March.

Recurring hospital-acquired infections: Focus now on COVID-19 – The LumiBio Solution

Andrew Metcalfe, Biotech Specialist at LumiBio discusses the persistent problem of hospital-acquired infections, and why now is the time to focus on reducing COVID- 19 transmission in clinical settings using the LumiBio solution.

Study explores COVID vaccine response in patients with impaired immune systems

A new UK study will examine the immune systems response to COVID-19 vaccinations in patients with immunosuppressed conditions

Sterilair PRO – Biological air treatment

Used in medical settings for over 20 years, Sterilair is now being used in a wide range of close-contact environments to maintain healthy air quality.

COVID-19 in pregnancy not linked with stillbirth or early neonatal death

According to a new study, COVID-19 infection in pregnancy is not associated with stillbirth or early neonatal death but it may increase the risk of pre-term birth.

COVID-19 update: Vaccinations & infection prevention and control (IPC)

Ruth Smith CEO of Active Care Group and its Christchurch Group division discusses the new highly virulent variant of COVID, vaccinations, and infection prevention and control (IPC).

EU allocates additional €500 million to COVAX facility

The European Union has allocated an additional €500 million to the COVAX facility, bringing its total contribution to €1 billion.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders